Jafron Biomedical Co.,Ltd. (SHE:300529)

Jafron Biomedical Revenue

Jafron Biomedical had revenue of 578.08M CNY in the quarter ending September 30, 2026, with 37.11% growth. This brings the company's total for the last twelve months to 2.07B, up 1.41% year-over-year. In the year 2025, Jafron Biomedical had annual revenue of 2.01B, down -24.86%. That makes Jafron Biomedical the 14,346th largest company in the world by revenue and 2,553rd in China.

• Revenue (ttm): 2.07B
• Revenue Growth: +1.41%
• P/S Ratio: 7.38
• Revenue / Employee: 898.02K
• Employees: 2,200
• Market Cap: 15.25B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medical Device Manufacturing Industry 2.01B 99.7%
• Other 5.34M 0.3%

By Geography

Chart

• China 1.94B 96.5%
• Overseas 71.11M 3.5%

Fiscal year ended Dec 31, 2025 See the full Jafron Biomedical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.01B	-665.50M	-24.86%
Dec 31, 2024	2.68B	754.97M	39.27%
Dec 31, 2023	1.92B	-569.09M	-22.84%
Jan 1, 2023	2.49B	-184.02M	-6.88%
Jan 1, 2022	2.68B	724.67M	37.15%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 8, 2026

Data Sources Report a data error